Stock Track | Cassava Sciences Stock Plunges 5.47% on Analyst Downgrade

Stock Track11-26

Cassava Sciences Inc (SAVA) stock plummeted 5.47% in pre-market trading on Tuesday, following an analyst downgrade by H.C. Wainwright.

H.C. Wainwright analyst Vernon Bernardino lowered the rating on Cassava Sciences from Buy to Neutral, removing the price target on the stock. The downgrade came after the company announced a disappointing development related to its Alzheimer's drug candidate.

The analyst action weighed heavily on investor sentiment, triggering a selloff in Cassava Sciences shares during the pre-market session. The stock's plunge erased a significant portion of the gains it had accumulated over the past few trading sessions.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment